Emerald Health Sciences Inc. Skye Bioscience, Inc. (SKYE) insider trading activity
Emerald Health Sciences Inc. is > 10% Shareholder of Skye Bioscience, Inc.. Currently has a direct ownership of 169 Million shares of SKYE, which is worth approximately $983 Million. The most recent transaction as insider was on Feb 22, 2023, when has been sold 58,020,650 shares (Common Stock) at a price of $0.03 per share, resulting in proceeds of $1,740,619. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
169M
0%
3M change
0%
12M change
Total Value Held
$983 Million
EHS
Emerald Health Sciences Inc.
> 10% Shareholder
Vancouver, A1